These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 13743428

  • 1. Monoamine oxidase inhibition.
    ROSENBLUM I, FERGUSON FC.
    Clin Pharmacol Ther; 1960; 1():692-3. PubMed ID: 13743428
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparative effects of monoamine oxidase inhibitors on monoamine oxidase and diamine oxidase.
    SHORE PA, COHN VH.
    Biochem Pharmacol; 1960 Oct; 5():91-5. PubMed ID: 13912256
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacologic aspects of monoamine oxidase inhibition.
    WEBB JL.
    Am J Cardiol; 1960 Dec; 6():1112-6. PubMed ID: 13783566
    [No Abstract] [Full Text] [Related]

  • 5. Histochemical demonstration in rat of monoamine oxidase inhibition of beta-phenyl-isopropyl hydrazine.
    MUSTAKALLIO KK, LEVONEN E, RAEKALLIO J.
    Science; 1961 Aug 04; 134(3475):344. PubMed ID: 13727138
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Significance of monoamine oxidase inhibition for the pharmacological and clinical effects of hydrazine derivatives.
    PLETSCHER A.
    Ann N Y Acad Sci; 1959 Sep 17; 80():1039-45. PubMed ID: 14433482
    [No Abstract] [Full Text] [Related]

  • 8. Studies on monoamine oxidase. 2: p-Methylphenyl hydrazine, a potent and selective monoamine oxidase inhibitor.
    ARAI A.
    Jpn J Pharmacol; 1960 Mar 17; 9():159-68. PubMed ID: 13683948
    [No Abstract] [Full Text] [Related]

  • 9. In vivo metabolism of serotonin and tryptamine: effect of monoamine oxidase inhibition.
    WEISSBACH H, LOVENBERG W, REDFIELD BG, UDENFRIEND S.
    J Pharmacol Exp Ther; 1961 Jan 17; 131():26-30. PubMed ID: 13784114
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Specific liver and brain monoamine oxidase inhibition by alkyl- and arylalkylhydrazines.
    HORITA A, McGRATH WR.
    Proc Soc Exp Biol Med; 1960 Apr 17; 103():753-7. PubMed ID: 14403108
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Monoamine liberators and monoamine oxidase inhibitors].
    LEUSEN I.
    Psychiatr Neurol (Basel); 1960 Jul 17; 140():154-64. PubMed ID: 13761295
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Monoamine oxidase inhibitors].
    MACIAS CASTRO I.
    Arch Hosp Univ; 1960 Jul 17; 12():330-3. PubMed ID: 13764845
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.